| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5645484 | Annals of Allergy, Asthma & Immunology | 2016 | 6 Pages |
Abstract
Because of systemic effects on the HPA axis, high doses of ICS should be avoided where possible. Adult patients undergoing high-dose or long-term ICS therapy should be monitored for cataracts.
Related Topics
Health Sciences
Medicine and Dentistry
Dermatology
Authors
Warner W. MD, Stanley J. MD,